1 / 8

Bioinformatics Market to Witness robust Growth till 2020 | Hexa Research

The rising incidences of chronic diseases globally coupled with the increasing demand of advanced drugs for the diagnosis of these diseases are expected to propel the growth for bioinformatics market.

Carrol
Download Presentation

Bioinformatics Market to Witness robust Growth till 2020 | Hexa Research

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Your Catalyst To a Lucrative Business Bioinformatics Market Share, Size, Analysis, Growth, Trends and Forecasts to 2020 | Hexa Research “The rising incidences of chronic diseases globally coupled with the increasing demand of advanced drugs for the diagnosis of these diseases are expected to propel the bioinformatics market growth.” The global Bioinformatics Market is projected to expand at a CAGR over 21% during the forecast period (2014 to 2020). In revenue terms, the industry could reach nearly USD 14 billion by 2020. It is propelled by growing demand for advanced drugs and prevalence of chronic diseases. Application of information technology for the effective management of biological information is known as bioinformatics. Affordable costs of DNA sequencing and strong support from private sector organizations & governments are factors that positively impact the global industry. Furthermore, steady developments in IT support for bioinformatics systems may fuel market demand in the forthcoming years. A number of research institutes focus greatly on discovering & developing novel drugs in the area of life sciences. Widespread adoption of bioinformatics in clinical diagnostics is a vital industry driver. Browse details of Report @ https://www.hexaresearch.com/research-report/bioinformatics-industry Follow Us:

  2. Your Catalyst To a Lucrative Business The global bioinformatics market is segmented on the basis of sectors, products & services, applications, and regions. Based on sectors, the industry is divided into environment biotechnology, animal biotechnology, forensic biotechnology, agriculture biotechnology, academics, forensic biotechnology, and medical biotechnology. The forensic biotechnology segment is a rapidly growing one because of high demand for DNA evidence in legal systems. The sub-segments of medical biotechnology are reproductive biotechnology, clinical diagnostics, drug development, gene therapy, and molecular medicines. Owing to high sunk costs, medical biotechnology holds the highest share in the overall market in terms of revenue. According to products & services, the worldwide industry is categorized into bioinformatics services, bioinformatics platform, and bioinformatics knowledge management tools. Bioinformatics tools are further segmented into generalized knowledge management tools and specialized knowledge management tools. Bioinformatics platforms include sequence alignment platforms, sequence analysis platforms, functional & structural analysis platforms, and sequence manipulation platforms. Bioinformatics services are classified into database management, sequencing service, data analysis, and others. Data analysis and database management are by far the most expensive because of these need human intervention for interpretation and technology for data organization. On the basis of applications, the global Bioinformatics Market is divided into molecular phylogenetics, proteomics, metabolomics, chemo informatics & drug design, transcriptomics, and others. Genomics is anticipated to be the largest market by 2020. And metabolomics may register the highest growth rate during the forecast period. The regional segments of the global Bioinformatics Market are Asia Pacific, North America, Europe, and Rest of the World. North America dominated the overall industry in 2014 owing to technological developments and continuous efforts towards drug discovery & development. The region may retain its leading position throughout the forecast period. Asia Pacific may expand at a remarkable rate because of medical tourism, high investments in healthcare IT, and greater CRO activities. Brazil, China, and India could create significant growth prospects in the forthcoming years. Prominent companies operating in the global industry are Life Technology Corporation, Biomax Informatics AG, CLC Bio, Id Business Solutions, and Nonlinear Dynamics Ltd. In order to understand & block the progression of cancer, researchers have identified certain proteins that get altered in different types of cancers. When these are targeted with drugs that block their activities, the progression of cancer can be halted to an extent. Researchers & scientists from the University of Cambridge and from Hungary utilized databases of genes that are involved in cancer. Follow Us:

  3. Your Catalyst To a Lucrative Business It was observed that cancer related proteins are strongly connected to the main protein networks. Some of the key proteins in the networks have the capacity to facilitate changes that convert healthy cells into cancer cells. The cancer proteins do not interact directly with another but through their surrounding first neighbors. The concerned researchers have successfully utilized computational methods to identify the exact proteins that need to be targeted by drugs. Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/healthcare-it- industry Follow Us:

  4. Your Catalyst To a Lucrative Business Table of Content of Bioinformatics Market Chapter 1. Executive Summary 1.1. Bioinformatics - Industry Summary and Critical Success Factors (CSFs) Chapter 2. Bioinformatics Industry Outlook 2.1. Market Segmentation 2.2. Market Size and Growth Prospects 2.3. Bioinformatics Market Dynamics 2.3.1. Market Driver Analysis 2.3.2. Market Restraint Analysis 2.4. Key Opportunities Prioritized 2.5. Industry Analysis - Porter's 2.6. Bioinformatics Market PESTEL Analysis, 2012 Chapter 3. Bioinformatics Product Outlook 3.1. Bioinformatics Platoforms 3.1.1. Bioinformatics Platforms Market Estimates and Forecasts, 2012 - 2020 (USD Million) 3.1.2. Sequence Analysis Platforms 3.1.2.1. Sequence Analysis Platforms Market Estimates and Forecasts, 2012 - 2020 (USD Million) 3.1.2.2. Structural and Functional Analysis Platforms 3.1.2.2.1. Structural and Functional Analysis Platforms Market Estimates and Forecasts, 2012 - 2020 3.1.2.3. Sequence Alignment Platforms 3.1.2.3.1. Sequence Alignment Platforms Market Estimates and Forecasts, 2012 - 2020 (USD Million) 3.1.2.4. Sequence Manipulation Platforms 3.1.2.4.1. Sequence Manipulation Platforms Market Estimates and Forecasts, 2012 - 2020 (USD Million) 3.1.2.5. Others 3.1.2.5.1.1. Other Platforms Market Estimates and Forecasts, 2012 - 2020 (USD Million) 3.2. Biocontent 3.2.1. Biocontent Market Estimates and Forecasts, 2012 - 2020 (USD Million) 3.2.2. Generalized Biocontent Tools 3.2.2.1. Generalized Biocontent Tools Market Estimates and Forecasts, 2012 - 2020 (USD Million) 3.2.3. Specialized Biocontent Tools 3.2.3.1.1. Specialized Biocontent Tools Market Estimates and Forecasts, 2012 - 2020 (USD Million) 3.3. Services 3.3.1. Bioinformatics Services Market Estimates and Forecasts, 2012 - 2020 (USD Million) Follow Us:

  5. Your Catalyst To a Lucrative Business 3.3.2. Sequencing 3.3.2.1. Sequencing Services Market Estimates and Forecasts, 2012 - 2020 (USD Million) 3.3.3. Data Analysis Services 3.3.3.1. Data Analysis Services Market Estimates and Forecasts, 2012 - 2020 (USD Million) 3.3.4. Database Management Services 3.3.4.1. Database Management Services Market Estimates and Forecasts, 2012 - 2020 (USD Million) 3.3.5. Other Services 3.3.5.1. Other Bioinformatics Services Market Estimates and Forecasts, 2012 - 2020 (USD Million) Chapter 4. Bioinformatics Application Outlook 4.1. Genomics 4.1.1. Genomics Market Estimates and Forecasts, 2012 - 2020 (USD Million) 4.2. Molecular Phylogenetics 4.2.1. Molecular Phylogenetics Market Estimates and Forecasts, 2012 - 2020 (USD Million) 4.3. Metabolomics 4.3.1. Metabolomics Market Estimates and Forecasts, 2012 - 2020 (USD Million) 4.4. Proteomics 4.4.1. Proteomics Market Estimates and Forecasts, 2012 - 2020 (USD Million) 4.5. Transcriptomics 4.5.1. Transcriptomics Market Estimates and Forecasts, 2012 - 2020 (USD Million) 4.6. Chemoinformatics and Drug Designing 4.6.1. Chemoinformatics and Drug Designing Market Estimates and Forecasts, 2012 - 2020 (USD Million) 4.7. Others 4.7.1. Other Applications Market Estimates and Forecasts, 2012 - 2020 (USD Million) Chapter 5. Bioinformatics Regional Outlook 5.1. North America 5.1.1. Bioinformatics Market Estimates and Forecasts, by Products, 2012 - 2020 (USD Million) 5.1.2. Bioinformatics Market Estimates and Forecasts, by Applications, 2012 - 2020 (USD Million) 5.2. Europe 5.2.1. Bioinformatics Market Estimates and Forecasts, by Products, 2012 - 2020 (USD Million) 5.2.2. Bioinformatics Market Estimates and Forecasts, by Applications, 2012 - 2020 (USD Million) 5.3. Asia Pacific 5.3.1. Bioinformatics Market Estimates and Forecasts, by Products, 2012 - 2020 (USD Million) 5.3.2. Bioinformatics Market Estimates and Forecasts, by Applications, 2012 - 2020 (USD Million) 5.4. RoW Follow Us:

  6. Your Catalyst To a Lucrative Business 5.4.1. Bioinformatics Market Estimates and Forecasts, by Products, 2012 - 2020 (USD Million) 5.4.2. Bioinformatics Market Estimates and Forecasts, by Applications, 2012 - 2020 (USD Million) Chapter 6 Competitive Landscape 6.1 Accelrys Inc. 6.1.1 Company Overview 6.1.2 Financial Performance 6.1.3 Product Benchmarking 6.1.4 Strategic Initiatives 6.2 IBM Life Sciences 6.2.1 Company Overview 6.2.2 Financial Performance 6.2.3 Product Benchmarking 6.2.4 Strategic Initiatives 6.3 3rd Millennium Inc. 6.3.1 Company Overview 6.3.2 Financial Performance 6.3.3 Product Benchmarking 6.3.4 Strategic Initiatives 6.4 Life Technologies Corporation 6.4.1 Company Overview 6.4.2 Financial Performance 6.4.3 Product Benchmarking 6.4.4 Strategic Initiatives 6.6 Agilent Technologies 6.6.1 Company Overview 6.6.2 Financial Performance 6.6.3 Product Benchmarking 6.6.4 Strategic Initiatives 6.6 Affymetrix 6.6.1 Company Overview 6.6.2 Financial Performance 6.6.3 Product Benchmarking 6.6.4 Strategic Initiatives 6.7 Celera Corporation 6.7.1 Company Overview Follow Us:

  7. Your Catalyst To a Lucrative Business 6.7.2 Financial Performance 6.7.3 Product Benchmarking 6.7.4 Strategic Initiatives 6.8 Rosetta Inpharmatics 6.8.1 Company Overview 6.8.2 Financial Performance 6.8.3 Product Benchmarking 6.8.4 Strategic Initiatives 6.9 BioWisdom Ltd. 6.9.1 Company Overview 6.9.2 Financial Performance 6.9.3 Product Benchmarking 6.9.4 Strategic Initiatives Chapter 7. Methodology and Scope 7.1. Research Methodology 7.2. Research Scope & Assumption 7.3. List of Data Sources Follow Us:

  8. Your Catalyst To a Lucrative Business About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: sales@hexaresearch.com Website - http://www.hexaresearch.com/ Visit Our Blog: https://hexaresearchinc.wordpress.com Follow Us:

More Related